Dr Harparkash Kaur BSc PhD CSci CChem FRSC

Assistant Professor Pharmacology

Background

 Dr Harparkash Kaur gained both her BSc with honours and PhD in chemistry from the Chelsea College (now Kings College), University of London.

PhD thesis: Free Radical Chemistry: Pericyclic Rearrangements and some new spin traps. 

Elected chartered chemist, fellow of the Royal Society of Chemistry in 1999 (CChem FRSC) and designated a chartered scientist (CSci) in 2005.

Harparkash joined LSHTM in 2001 as staff on the Gates Malaria Partnership and is a founder member of the artemisinin combination therapy consortium. She is the lead investigator of the drug quality project(www.actconsortium.org/drugquality).

Affiliation

Centres

Teaching

Research

Harparkash set up the bio analytical laboratory at LSHTM. As an analyst she devised high performance liquid chromatography (HPLC) based methods applicable to varying fields of research such as determining the levels of free radicals in disease state and levels of endogenous antioxidants. Her present research has involved developing / validating HPLC and simple chemical methods to test the quality as well as levels of drugs in patient samples and measuring the levels of insecticids on treated nets and indoor residual spraying that are used as the major mode of intervention in the fight against malaria. The field friendly methods that she has devised for the detection of artemisnin derivatives and for the detection of insecticides have separate granted patents held by the LSHTM. The focus of her work recently been to determine the quality of drugs, levels of antimalarial drugs on filter paper adsorbed blood samples and amounts of insecticides on bed nets from a number of trials ongoing/planned in Sub-Saharan Africa.

Research areas

  • Pharmacokinetics
  • Qualitative methods
  • Vector control

Disciplines

  • Pharmacology

Disease and Health Conditions

  • Infectious disease
  • Malaria
  • Neglected Tropical Diseases (NTDs)

Regions

  • South Asia
  • Sub-Saharan Africa (all income levels)
  • Sub-Saharan Africa (developing only)

Countries

  • Afghanistan
  • Cambodia
  • Equatorial Guinea
  • Ghana
  • Nigeria
  • Rwanda
  • Tanzania

Other interests

  • ACT
  • Antimalarial Drug Resistance
  • Dried Blood Spots
  • Drug Efficacy
  • Drug Measurement
  • Drug Quality
  • Drug Screening
  • Drug Trials
  • Insecticides On Bednets And Free Radical Methodology
  • Malaria Centre
  • Oxidative Stress
  • Pharmaceuticals
Back to top